瑞亚诺丹迪特尔类物质加拉约和3-epi-Garajonone的总合成
Jin-Bao Qiao1, Long Meng1, Jia-Yi Pei1
1Key Laboratory of Applied Surface and Colloid Chemistry & School of Chemistry and Chemical Engineering, Shaanxi Normal University, 620 West Chang'an Ave, Xi'an, 710119, China.
Angewandte Chemie (International ed. in English)
|October 2, 2024
概括
研究人员首次实现了对复杂的酸二甲类化合物加拉隆及其表的化学合成. 这一突破利用了复杂烯合成的新两阶段策略.
科学领域:
- 有机化学 有机化学
- 自然产品的合成自然产品的合成
- 化物化学 化物化学
背景情况:
- 瑞安二烯酸是复杂的,高度氧化的天然产品.
- 它们复杂的结构带来了重要的合成挑战.
- 像加拉乔这样的化合物的自然丰富性往往很低.
研究的目的:
- 为了实现第一个化学合成的加拉和其表皮,3-epi-garajonone.
- 开发一个多功能合成平台,用于其他氨酸二甲.
- 为了克服与高度氧化烯相关的合成挑战.
主要方法:
- 一个由基生物合成启发的两阶段合成策略.
- 早期的催化赫克/碳化化级联取消用于框架建设.
- 晚期选择性氧化还原操纵以达到所需的氧化状态.
主要成果:
- 成功合成了garajonone,一种天然存在的氨酸二甲化物.
- 成功合成了3-epi-garajonone,这是加拉的一种epimer.
- 快速碳框架建设方法的演示.
结论:
- 开发的合成策略使得人们能够有效地获取加拉和其胺.
- 这项研究提供了一个基础平台,用于合成各种氨酸二甲和类似物.
- 这项研究强调了复杂分子合成中的级联反应和选择性氧化还原操作的力量.
相关概念视频
Acid-Catalyzed Ring-Opening of Epoxides
7.1K
Epoxides that are three-membered ring systems are more reactive than other cyclic and acyclic ethers. The high reactivity of epoxides originates from the strain present in the ring. This ring strain acts as a driving force for epoxides to undergo ring-opening reactions either with halogen acids or weak nucleophiles in the presence of mild acid. The acid catalyst converts the epoxide oxygen, a poor leaving group, into an oxonium ion, a better leaving group, making the reaction feasible. The...
7.1K
Base-Catalyzed Ring-Opening of Epoxides
8.3K
Due to their highly strained structures, epoxides can readily undergo ring-opening reactions through nucleophilic substitution, either in the presence of an acid or a base. The nucleophilic substitution reactions in the presence of acid are called acid-catalyzed ring-opening reactions, and nucleophilic substitution reactions in the presence of a base are called base-catalyzed ring-opening reactions. Epoxides undergo base-catalyzed ring-opening reactions in the presence of a strong nucleophile...
8.3K
Heart Failure Drugs: Inotropic Agents
535
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
535
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
716
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
716
GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K


